NovioScan,
wearable
ultrasound care

Novioscan is founded in 2014 and holds its office at the NovioTech Campus in Nijmegen, The Netherlands. The development of wearable ultrasound devices was a result of technical innovation combined with the clinical need to help children who do not sense their bladder.

After 4 years of development Novioscan launched the SENS-U KIDS in 2018 and made it available for the treatment of children in the age of 6-12 years. The SENS-U supports people who do not sense a full bladder. The KIDS version is currently available in Europe. The next generation of the SENS-U will be intended for people of all ages dealing with incontinence and who need support with bladder management.

Novioscan was acquired by Essity in 2020.

Our news

October 9, 2025

819 Capital Partners launches 819 Seed Fund!

Deventer, 9 October 2025 – 819 Capital Partners announces the launch of 819 Seed Fund, a new €9 million fund established with support from the Netherlands Enterprise Agency (RVO). 819 Seed Fund is designed to address the growing demand for venture capital among early-stage deep tech and med tech companies, offering ticket sizes from €250k - €1.5M. Its mission is to help entrepreneurs develop, validate, and scale breakthrough technologies in the Netherlands. By investing at...

Continue reading
June 27, 2025

819 Capital makes follow-on investment in ScoutinScience to scale AI-driven research

Deventer, 27 June 2025 – 819 Capital reaffirms its commitment to ScoutinScience by joining their €1 million growth investment round, alongside new angel investors with AI-expertise. The investment will support the further development and international expansion of the company’s AI-powered research valorisation platform. ScoutinScience uses advanced AI and natural language processing to systematically identify, assess, and accelerate the real-world impact of academic research. Its proprietary models uncover untapped innovation potential at scale, enabling universities, TTOs,...

Continue reading